ABBV-CLS-616
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-CLS-616, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants [Phase 1]